- South San Francisco, California, United States
- On-site
- Full-time · Principal
- $142K–$263K per year
- 3–5 years
The Principal Scientist in Translational Medicine Oncology will support one or more translational programs contributing to the clinical development of oncology therapeutics, designing, developing, and implementing pharmacodynamic and predictive biomarker strategies across early- and late-stage clinical trials.
Compensation
The expected salary range for this position based on the primary location of California is $141,500 - $262, 900. A discretionary annual bonus may be available based on individual and Company performance.
Responsibilities
- Develop and execute biomarker strategies for oncology therapeutics from first-in-human through registrational clinical studies
- Partner cross-functionally with Research, Clinical Development, Clinical Pharmacology, Biostatistics, Regulatory, and Companion Diagnostics to ensure scientific alignment and enable data-driven decision-making
- Contribute to cross-functional project teams, ensuring alignment with overall program goals, timelines, and translational objectives
- Develop and deploy next-generation biomarker assays across clinical programs to support development decisions and translational research efforts in oncology
- Design and implement translational research plans leveraging clinical samples, multi-omic profiling, spatial biology, single-cell technologies, and emerging AI-enabled analytical approaches, including agentic AI tools, to uncover mechanisms of response, resistance, tumor microenvironment interactions, and disease evolution
Requirements
- PhD, MD, or MD/PhD in molecular biology, cancer biology, immunology, computational biology, bioinformatics, or a related field